Whiteoak

Managing Partner Gregory Jones and Partner Graham Whitehead lead the investment committee and oversee all deal origination, execution, and portfolio management. Both co-founded the firm in 2010 and are the primary decision-makers on new investments and exits. Their backgrounds in Australian institutional private equity and investment banking shape the firm's operationally focused investment approach.

Whiteoak pursues control buyouts in companies with enterprise values typically between $20 million and $100 million. The firm focuses on profitable lower-mid-market businesses undergoing succession events, corporate carve-outs, or management buyouts. Whiteoak does not participate in venture capital or early-stage growth rounds, maintaining a strict discipline around cash-flow-positive targets.

Whiteoak is a traditional private equity fund manager, not a family office. The firm raises capital from institutional investors, including Australian superannuation funds, for its vintage-structured buyout funds. It is structured as an independent partnership with a general-partner/limited-partner model.

Whiteoak sources transactions through a network of founder-level relationships, Australian corporate advisors, and accounting firms serving privately held businesses. The firm focuses on proprietary and limited-auction processes where its ability to navigate complex ownership transitions — particularly family successions — provides a competitive advantage. The firm's lower-mid-market focus screens out most large-scale auction processes conducted by global investment banks.

Whiteoak's mandate is restricted to Australia and New Zealand. The firm has completed transactions in both countries, applying its buy-and-build and operational improvement strategy across the trans-Tasman market. There is no public record of investments outside this geography.

Whiteoak operates as a lead or sole sponsor on its control buyouts and does not typically co-invest alongside other private equity general partners. The firm's focus on sub-$100 million enterprise-value companies means co-investment syndication with other funds is unusual. Limited partners in Whiteoak's funds may receive co-investment rights on a deal-by-deal basis.

Whiteoak does not invest in resources, mining services, or pure-play commodities — sectors it has stated are inconsistent with its operational-value-creation approach and desired risk profile. The firm also avoids early-stage technology businesses, biotech, and real estate development, concentrating instead on business services, industrial technology, healthcare services, and select consumer verticals.